3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
8
Stomach Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Microsatellite Stable Rectal Carcinoma
1
Melanoma
1
Hemangiosarcoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Adenocarcinoma Of Esophagus
1
Interventions
tislelizumab
4
pembrolizumab
4
Injections
4
toripalimab
3
sotorasib
1
serabelisib
1
olaparib
1
nedaplatin
1
mirdametinib
1
erdafitinib
1
envafolimab
1
darolutamide
1
atezolizumab
1
adagrasib
1
abiraterone
1
Taxes
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Fulvestrant
1
Drug Therapy
1
CD3 Complex
1
Bevacizumab
1
Antineoplastic Agents
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
balstilimab
×
90 days
×
Clear all
No trials found.